Adam Arany

Repurposing High-Throughput Image Assays Enables Biological Activity Prediction for Drug Discovery

In both academia and the pharmaceutical industry, large-scale assays for drug discovery are expensive and often impractical, particularly for the increasingly important physiologically relevant model systems that require primary cells, organoids, whole organisms, or expensive or rare reagents. We hypothesized that data from a single high-throughput imaging assay can be repurposed to predict the biological activity of compounds in other assays, even those targeting alternate pathways or biological processes. Indeed, quantitative information extracted from a three-channel microscopy-based screen for glucocorticoid receptor translocation was able to predict assay-specific biological activity in two ongoing drug discovery projects. In these projects, repurposing increased hit rates by 50- to 250-fold over that of the initial project assays while increasing the chemical structure diversity of the hits. Our results suggest that data from high-content screens are a rich source of information that can be used to predict and replace customized biological assays.

A Comprehensive Comparison of Two MEDLINE Annotators for Disease and Gene Linkage: Sometimes Less is More

Text mining is popular in biomedical applications because it allows retrieving highly relevant information. Particularly for us, it is quite practical in linking diseases to the genes involved in them. However text mining involves multiple challenges, such as (1) recognizing named entities (e.g., diseases and genes) inside the text, (2) constructing specific vocabularies that efficiently represent the available text, and (3) applying the correct statistical criteria to link biomedical entities with each other. We have previously developed Beegle, a tool that allows prioritizing genes for any search query of interest. The method starts with a search phase, where relevant genes are identified via the literature. Once known genes are identified, a second phase allows prioritizing novel candidate genes through a data fusion strategy. Many aspects of our method could be potentially improved. Here we evaluate two MEDLINE annotators that recognize biomedical entities inside a given abstract using different dictionaries and annotation strategies. We compare the contribution of each of the two annotators in associating genes with diseases under different vocabulary settings. Somewhat surprisingly, with fewer recognized entities and a more compact vocabulary, we obtain better associations between genes and diseases. We also propose a novel but simple association criterion to link genes with diseases, which relies on recognizing only gene entities inside the biomedical text. These refinements significantly improve the performance of our method.

Gene Prioritization Using Bayesian Matrix Factorization with Genomic and Phenotypic Side Information

Motivation Most gene prioritization methods model each disease or phenotype individually, but this fails to capture patterns common to several diseases or phenotypes. To overcome this limitation, we formulate the gene prioritization task as the factorization of a sparsely filled gene‐phenotype matrix, where the objective is to predict the unknown matrix entries. To deliver more accurate gene‐phenotype matrix completion, we extend classical Bayesian matrix factorization to work with multiple side information sources. The availability of side information allows us to make non‐trivial predictions for genes for which no previous disease association is known. Results Our gene prioritization method can innovatively not only integrate data sources describing genes, but also data sources describing Human Phenotype Ontology terms. Experimental results on our benchmarks show that our proposed model can effectively improve accuracy over the well‐established gene prioritization method, Endeavour. In particular, our proposed method offers promising results on diseases of the nervous system; diseases of the eye and adnexa; endocrine, nutritional and metabolic diseases; and congenital malformations, deformations and chromosomal abnormalities, when compared to Endeavour. Availability and implementation The Bayesian data fusion method is implemented as a Python/C++ package: https://github.com/jaak‐s/macau. It is also available as a Julia package: https://github.com/jaak‐s/BayesianDataFusion.jl. All data and benchmarks generated or analyzed during this study can be downloaded at https://owncloud.esat.kuleuven.be/index.php/s/UGb89WfkZwMYoTn.

Repurposed High-Throughput Images Enable Biological Activity Prediction For Drug Discovery

We repurpose a High-Throughput (cell) Imaging (HTI) screen of a glucocorticoid receptor assay to predict target protein activity in multiple other seemingly unrelated assays. In two ongoing drug discovery projects, our repurposing approach increased hit rates by 60- to 250-fold over that of the primary project assays while increasing the chemical structure diversity of the hits. Our results suggest that data from available HTI screens are a rich source of information that can be reused to empower drug discovery efforts.